Cargando…
Thrombogenicity assessment of Pipeline, Pipeline Shield, Derivo and P64 flow diverters in an in vitro pulsatile flow human blood loop model
Flow diversion is a disruptive technology for the treatment of intracranial aneurysms. However, these intraluminal devices pose a risk for thromboembolic complications despite dual antiplatelet therapy. We report the thrombogenic potential of the following flow diversion devices measured experimenta...
Autores principales: | Girdhar, Gaurav, Ubl, Samantha, Jahanbekam, Reza, Thinamany, Sinduja, Belu, Anna, Wainwright, John, Wolf, Michael F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350389/ https://www.ncbi.nlm.nih.gov/pubmed/30723811 http://dx.doi.org/10.1016/j.ensci.2019.01.004 |
Ejemplares similares
-
Thrombogenicity assessment of Pipeline Flex, Pipeline Shield, and FRED flow diverters in an in vitro human blood physiological flow loop model
por: Girdhar, Gaurav, et al.
Publicado: (2018) -
Thrombogenicity of flow diverters in an ex vivo shunt model: effect of phosphorylcholine surface modification
por: Hagen, Matthew W, et al.
Publicado: (2017) -
Preclinical safety and efficacy evaluation of the Pipeline Vantage Embolization Device with Shield Technology
por: Starke, Robert M, et al.
Publicado: (2020) -
In vitro methodology for medical device material thrombogenicity assessments: A use condition and bioanalytical proof‐of‐concept approach
por: Wolf, Michael F., et al.
Publicado: (2020) -
Comparison of the Thrombogenicity of a Bare and Antithrombogenic Coated Flow Diverter in an In Vitro Flow Model
por: Lenz-Habijan, T., et al.
Publicado: (2019)